EFNA1 and ovarian cancer: In a proof-of-concept study, magnetic NPs (MNPs) functionalized with ephrin-A1 mimetic peptides removed ovarian cancer cells overexpressing the EphA2 receptor from peritoneal fluid in a murine model of ovarian cancer.